Sébastien Simoncelli
@ssimoncellimwtc.bsky.social
I help life sciences founders to generate more impactful opportunities on Bluesky.
Founder’s Checklist: 5 Things to Post This Month
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
August 22, 2025 at 12:02 PM
Founder’s Checklist: 5 Things to Post This Month
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Bluesky Engagement & Science Communication
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
August 22, 2025 at 7:02 AM
Bluesky Engagement & Science Communication
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Breaking Down Regulatory Wins
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
August 21, 2025 at 12:02 PM
Breaking Down Regulatory Wins
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
Why Bluesky is Perfect for Life Sciences Thought Leadership?
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
August 21, 2025 at 7:02 AM
Why Bluesky is Perfect for Life Sciences Thought Leadership?
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
August 20, 2025 at 12:02 PM
Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
What Bluesky Teaches Founders About Trust?
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
August 20, 2025 at 7:02 AM
What Bluesky Teaches Founders About Trust?
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Way to Make Complex Science Engaging
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
August 19, 2025 at 12:03 PM
Way to Make Complex Science Engaging
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
How to Share Clinical Milestones on Bluesky
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
August 19, 2025 at 7:14 AM
How to Share Clinical Milestones on Bluesky
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
Bluesky vs LinkedIn: Where Should Founders Focus?
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
August 18, 2025 at 12:02 PM
Bluesky vs LinkedIn: Where Should Founders Focus?
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
Why Founders Struggle with Translating Science to Social Media?
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
August 18, 2025 at 7:02 AM
Why Founders Struggle with Translating Science to Social Media?
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech